Buckley, N. E., Forde, C., McArt, D. G., Boyle, D. P., Mullan, P. B., James, J. A., . . . Salto-Tellez, M. (2016). Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment. Sci Rep.
Citação norma ChicagoBuckley, Niamh E., Claire Forde, Darragh G. McArt, David P. Boyle, Paul B. Mullan, Jacqueline A. James, Perry Maxwell, Stephen McQuaid, and Manuel Salto-Tellez. "Quantification of HER2 Heterogeneity in Breast Cancer–implications for Identification of Sub-dominant Clones for Personalised Treatment." Sci Rep 2016.
MLA引文Buckley, Niamh E., et al. "Quantification of HER2 Heterogeneity in Breast Cancer–implications for Identification of Sub-dominant Clones for Personalised Treatment." Sci Rep 2016.